Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery dis (Q38462674)
Jump to navigation
Jump to search
scientific article published on 11 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery dis |
scientific article published on 11 October 2012 |
Statements
1 reference
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery dis (English)
1 reference
Evan A Stein
1 reference
Robert Dufour
1 reference
Claude Gagne
1 reference
Daniel Gaudet
1 reference
Cara East
1 reference
Joanne M Donovan
1 reference
Wai Chin
1 reference
Diane L Tribble
1 reference
Mary McGowan
1 reference
11 October 2012
1 reference
1 reference
Identifiers
1 reference